Therapeutic plasma exchange in acute disseminated encephalomyelitis in children.
Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the central nervous system that is probably due to an autoimmune mechanism with an acute presentation and a monophasic course. The management of patients with ADEM is based on supportive therapy, corticosteroids, and intravenous immunoglobulin, and in selected cases, with therapeutic plasma exchange (TPE). The aim of our study is to evaluate the efficacy of TPE, as adjuvant therapy in pediatric patients with ADEM. We retrospectively reviewed the medical records of children with the diagnosis of ADEM between 2009 and 2011 to which TPE was indicated and were admitted in the ICU of Hospital Sant Joan de Deu (Spain). The diagnosis of ADEM was made by clinical and laboratory criteria and by the presence of compatible lesions on cranio-spinal Magnetic Resonance Imaging (MRI). For signaling TPE, we followed the guidelines established by the American Association of Apheresis (ASFA) in 2010. Five cases were identified. The predominant neurological symptoms in our patients were: altered level of consciousness, seizures, motor deficits, cranial nerve disorders, and aphasia. Most important demyelinating lesions were located in cortical and subcortical white matter of the brain and highlighted brainstream. Patients performed between 4 and 5 sessions, with no reported side effects. Progressive clinical improvement was evident in all patients, with good neurosensory response to stimulation, cessation of seizures, and recovery of limb mobility. Nowadays, one patient's right paresis persists and another suffers epileptic seizures. None of the cases in our series presented new episodes of demyelination. Due to the suggested immune-mediated pathogenesis of ADEM, treatment is based on immunomodulatory agents, being glucocorticoids the most important ones. The treatment can be complemented with intravenous immunoglobulin and plasmapheresis. Available data suggests that plasma exchange is beneficial in children with ADEM who fail these treatments. The good tolerance of the procedure without adverse reactions and the progressive neurological improvement detected in the reviewed cases suggest that the use of TPE in pediatric patients is a good therapeutic option when performed in an experienced center.
Pediatric Intensive Care Unit, Hospital Sant Joan De Déu, Barcelona, Spain.
Cristina
C
Borras-Novell
Banc de Sang i Teixits, Barcelona, Spain.
Enric
E
García Rey
Pediatric Intensive Care Unit, Hospital Sant Joan De Déu, Barcelona, Spain.
Luis Francisco
LF
Perez Baena
Pediatric Intensive Care Unit, Hospital Sant Joan De Déu, Barcelona, Spain.
Iolanda
I
Jordan Garcia
Banc de Sang i Teixits, Barcelona, Spain.
Dolors
D
Catella Cahiz
Pediatric Intensive Care Unit, Hospital Sant Joan De Déu, Barcelona, Spain.
Francisco
F
Cambra
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004673:Encephalomyelitis, Acute Disseminated / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D056747:Immunomodulation; D010951:Plasma Exchange; D012189:Retrospective Studies
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous
apheresis; demyelinating disease; neurologic indications; paediatric patients; plasmapheresis